Background:Hyperglycemia is common and associated with increased morbidity and
Introduction:
There are several firmly established risk factors for cardiovascular disease such as family history, increase age, smoking, diabetes, high blood cholesterol, hypertension, overweight and physical inactivity. Diabetes mellitus is associated with a high risk of CHD(1).Subjects with diabetes have a substantially increased risk of death after ACS as compared with nondiabetic age matched controls (2). High blood glucose levels in patients admitted with ACS are common and are associated with an increased risk of death in both diabetics and nondiabetics (3).The high prevalence of undiscovered abnormal glucose metabolism among patients with ACS compatible with the prediabetic state as well as frank diabetes, may in part explain the association between admission glucose levels and mortality especially who are not diagnosed as having diabetes at the time of ACS (4).Although hyperglycemia itself may be detrimental for the ischaemic myocardium, in many patients it may rather represent a marker of the metabolic abnormalities clustered in the insulin resistant syndrome, which is associated with CVD (5).Admission hyperglycemia is a strong risk factor for mortality in patients with ACS and may be even stnger than a previous history of diabetes. Recent evidences have shown that chronic glucose deregulation, as assessed by glycated hemoglobin (HBA1c), levels may also be of prognostic value with a regard to future the cardiovascular disease. Moreover acute glycometabolic disturbances may also have a negative impact on outcome as elevated glucose levels on admission are associated with increased adverse events, irrespective of diabetic status (6). 
Results:
Our study conducted on 150 patients 86 male and 64 female was admitted to CCU of Sohag University hospitals with ACS and patients were divided into 3 groups: Group A which includes 50 patients with euglycemia. Group B which include 50 patients with hyperglycemia and not known to be diabetic. Group C which include 50 patients with hyperglycemia and known to be diabetic. with age ranging from 39 year to 90 years with mean age 60.9As regards prevalence of hypertension between studied groups we found that there were a statistically significant difference between group A and group C (P<0.0001), group B and group C (P<0.003) but no statistically significant difference between group A and group B (p=0.12).
Also we found that there were no statistically significant between three groups as regards prevalence of cigarette smoking (P=0.44). We found insignificant difference between three groups as regards type of ST segment deviation at presentation. as regard lipid profile comparison between three groups we found that there were statistically significant difference between the three groups as regards mean total cholesterol (P=0.0001), mean serum triglycerides (P=0.0001) and mean low density lipoprotein (P<0.0001) and also significant difference between group (A, B) and group C as regard HDL (P=0.023) but no significant difference between group A and group B as regard HDL. In our study we found that there were a statistically significant difference as regards mean random blood sugar between (group A and group B) P<0.0001,(group A and group c) P<0.0001,but there were insignificant difference between (group B and group C) P=0.53 .Also we found that there were a statistically significant difference as regards mean serum glycosylated haemoglobin *HbA1c* between group A and group C (P<0.0001), group B and group C (P<0.0001) but no statistical difference between group A and group B (p=0.42). In this study we found that there were no significant difference between three groups as regards mean cardiac specific creatine phosphokinase (P=0.26) and Toponin ( P=0.09) . Follow up 30 day morbidity and mortality of studied population:In our study we found that there were highly significant difference between group A and group (B & C) as regards morbidity at 30 days follow up (P=0.005) but there were insignificant difference between group B and group C (P=0.07). But there were no significant difference between the three groups as regard type of morbidity (P=0.26). as regard follow up mortality after 30 day there were no significant difference between three groups (P=0.30). 
Discussion:
In our study we found that admission hyperglycemia largely affects the outcomes in diabetic patients presented by ACS this result were in concordance to Capes et al that demonstrated the relative risk of in-hospital death in non diabetic patients with acute myocardial infarction (AMI) with admission glucose > 110 mg/dL was 3.9 compared with non diabetic AMI patients who were normoglycemic. Among AMI patients with diabetes, those with admission glucose > 180 mg/dL had a 70% relative increase in the risk of in-hospital death compared with diabetic patients with normal admission glucose values(3) Similarly Foo et al demonstrated a near-linear relationship between higher admission glucose levels and higher rates of left ventricular failure and cardiac death among 2127 patients with ACS which were also in concordance to our results in that admission hyperglycemia largely affects the outcomes in diabetic patients presented by acute coronary syndrome. (6) Meier et al showed higher long-term mortality rates and larger infarct size (measured by creatine kinase and MBfraction levels) among hyperglycemic AMI patients both with and without diabetes ,these findings of Meier et al were in concordance to our results in that admission hyperglycemia largely affects the outcomes in patients with or without diabetes presented by ACS. (7) Studies by Wahab et al and Stranders et al have also suggested that admission hyperglycemia associated risk is the highest in AMI patients without previously known diabetes, these findings of Wahab et al and Stranders et al were disconcordant to our results in that the higher incedence of admission hyperglycemia and the poor outcomes occur in patients without known history of diabetes while in our study the higher incidence of admission hyperglycemia and the poor outcomes occur in patients with known history of diabetes, although this disconcordence these findings were in agree with our results in that admission hyperglycemia had a great impact on outcoumes in patients presented by acute coronary syndrome even more than the previous history of diabetes (8)(9).As regards the mean serum level of Glycosylatedhemoglubin (HBA1c) at admission among patients in the study, we found that there were a statistically significant difference between group (A&B) and group C As regards the mean serum level of Glycosylated hemoglubin at admission. Turner et al reported a significant difference between their study subgroups as regards the mean serum level of Glycosylatedhemoglubin at admission which were translated to a higher incidence of recurrent ischemia and mortality at 30 days follow up in the patients with higher mean serum level of Glycosylatedhemoglubin at admission which means that high mean serum level of Glycosylatedhemoglubin at admission had a significant impact on the outcomes in diabetic patients presented by ACS, these findings of Turner et al were in concordance to our results in that high serum level of Glycosylatedhemoglubin at admession is largely affects the outcomes in diabetic patients presented by acute coronary syndrome. (11) As regards the number of patients with morbidity and Mortality at 30 days follow up among patients in the study, we found that there were a statistically significant difference between group A and group (B, C) As regards the number of patients with Morbidity and Mortality at 30 days follow up which means that admission hyperglycemia had a great impact on the outcomes in diabetic patients presented by acute coronary syndrome.All previously mentioned studies reported that admission hyperglycemia were associated with poor outcomes in patients presented by acute coronary syndrome in the form of increased rate of recurrent ischemia and mortality at short and long term durations which were in concordance to our results that admission hyperglycemia had a great impact on the outcomes in patients with or without diabetes presented by acute coronary syndrome. (3, 6, 7, 8, 9, 10, 4, 11, 12, 13) .In our study we found that age, gender, cigarette smoking has no impact on prognosis of acute coronary syndrome. As regards the age distribution among patients in the study we found that there was no statistically significant difference between three groups as regards age distribution which means that age had no impact on the outcome in patients presented by acute coronary syndrome.Turner et al who studied the Risk factors for coronary artery disease in noninsulin dependent diabetes mellitus agreed with our results in that age had no impact on the outcome in patients presented by acute coronary syndrome. (11)Also Surekha et al who studied the risk factors for coronary heart disease in diabetes mellitus agreed with our results in that age had no impact on the outcome in patients presented by acute coronary syndrome. (12).Also our findings are similar to the findings reported by Damaris et al who studdied Admission glycaemia and its outcomes in patients with acute coronary syndrome in that age had no impact on the outcome in patients presented by acute coronary syndrome. (13). As regards the sex distribution among patients in the study we found that there were no statistically significant difference three groups.All the three studies of Turner et al, Surekha et al and Damaris et al reported that there was no difference in sex distribution between the studies subgroups which means that sex had no impact on the outcome in diabetic patients presented by acute coronary syndrome. (11, 12,13) As regards Cigarette smoking among patients in the study we found that there was no statistically significant difference between the three groups. Turner et al and Surekha et al reported that there were no difference in prevalance of Cigarette smoking between the studied subgroups which means that Cigarette smoking had no impact on the outcome in patients presented by acute coronary syndrome which were agreed with our results. (11, 12).Also Damaris et al and Norhammar et al reported a significant difference between their study subgroups as regards prevalance of Cigarette smoking which means that Cigarette smoking had a significant impact on the outcome in patients presented by acute coronary syndrome, this finding were disconcordant with our results most probably due to the small number of patients in our study (13, 14) . As regards the prevalence of Hypertension among patients in the study we found that there were statistically significant difference between group (A&B) and group C As regards prevalance of Hypertension.Turner et al and Surekha et al reported that there were no difference in prevalance of hypertention between the studied subgroups which means that hypertention had no impact on the outcome in diabetic patients presented by acute coronary syndrome which were disagreed with our results. (11, 12)On the contrary Damaris et al reported a significant difference between their study subgroups as regards prevalance of hypertention which means that hypertention had a significant impact on the outcome in diabetic patients presented by acute coronary syndrome, these finding is in concordance with our results that hypertension had impact on the outcome in diabetic patients presented by acute coronary syndrome (13). As regards ST segment deviation (ST elevation or depression) among patients in the study, we found that there was no statistically significant difference between the three groups as regards ST segment deviation. Norhammar et al reported a non significant difference between their study subgroups as regards ST segment deviation which means that ST segment deviation had a non significant impact on the outcomes in patients presented by acute coronary syndrome. (4)In our result we found that the mean serum level of total cholesterol, mean serum level of triglycerides, mean serum level of high denesity lipoprotein and mean serum level of high denesity lipoprotein among patients in the study, there were a statistically significant difference between the three groups which means that elevated serum lipids had impact on the outcomes in patients presented by acute coronary syndrome. We found also that there was no statistically significant difference between the three groups as regards the number of patients with positive Troponin. Turner et al reported a non significant difference between their study subgroups as regards the number of patients with positive Troponin which means that positive Troponin had a non significant impact on the outcomes in diabetic patients presented by acute coronary syndrome, these findings of Turneret al were in concordance to our results in that positive Troponin had no impact on the outcomes in patients presented by acute coronary syndrome (11).
Conclusions:
In our study we found that there was highly significant difference between group A (euglycemia) and group B+C (Group B =hyperglycemia and not known to be diabetic, C= hyperglycemia and known to be diabetic) as regard morbidity.This mean that hyperglycemia on admission associated with high risk of in hospital complication and 30 day follow up morbidity in patients both with and without diabetes mellitus but more in diabetic patients.We found also increase risk of mortality in patients admitted with hyperglycemia comparable to patients with euglycemia.Hyperglycemia is common, frequently untreated, and strongly associated with adverse outcomes in patients hospitalized with ACS. Multiple gaps still exist in our understanding of the relationship between elevated glucose and adverse outcomes, most importantly, whether hyperglycemia is a marker or a mediator of higher mortality and whether treatment of hyperglycemia improves outcomes. Addressing these knowledge gaps in future studies may provide an opportunity to improve care and outcomes in patients with ACS. 
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